NUTX · NASDAQ · Medical - Care Facilities

Nutex Health (NUTX)

Operates small-format hospitals and physician networks tied to out-of-network reimbursement.

$202.98
vs last close−5.84 (−2.80%)
Loading prices…

Nutex Health, Inc.NUTX
Health Care

Runs micro-hospitals, specialty hospitals, hospital outpatient departments, and physician-network services, with real estate supporting facility operations. Revenue is concentrated in the hospital division, and collections depend on insurer-paid out-of-network claims, No Surprises Act dispute resolution, and disciplined facility ramp-up.

Operates a physician-led healthcare platform built around micro-hospitals, specialty hospitals, hospital outpatient departments, and population health management. The hospital division provides facility and physician services, while the population health division manages independent physician associations and physician-group support services.

The footprint is concentrated in the United States, with facilities and physician networks spread across multiple states. A real estate division supports the operating model through hospital buildings and related facility assets rather than a separate consumer offering.

Execution depends on keeping small acute-care facilities staffed, expanding or ramping hospitals on schedule, and converting out-of-network claims into insurer collections. No Surprises Act Independent Dispute Resolution and remediation of reporting-control issues are documented structural dependencies.

Company facts

CEOThomas T. Vo
ListedApr 4, 2022
ExchangeNASDAQ
HeadquartersHouston, TX
CountryUnited States
Employees944
CIK0001479681
ISINUS67079U3068

Market cap$1.44B
EPS (ttm)$25.28
P/E (ttm)8.26
ROE51.9%
P/B3.64
P/S1.70
Dividend yieldDiv yield
Beta2.00vs XLV 0.23

Price target$310.00+48.5%Average of 4 analysts
ConsensusBuy4 of 4 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 11, 2026Lake StreetReiterate
Rating: Target: $235
Rating: BuyTarget: $310
Jun 26, 2026B. RileyInitiate
Rating:
Rating: Buy
Jun 2, 2026Lake StreetTarget
Target:
Target: $235

Next report
Nov 17, 26
in 55 days
EPS estimate
$5.71
Revenue estimate
$215.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Oct '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported$11.12$2.56−$2.95$7.76$1.61$6.52$9.38Pending
Estimate−$0.12$3.04−$1.43$1.81$5.56$3.99$4.95$5.71
Surprise+9,366.7%−15.8%−105.8%+328.7%−71.0%+63.4%+89.5%

RevenueReportedEstimate

Mar '25May '25Oct '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported$257.6M$211.8M$244.0M$267.8M$151.7M$216.5M$210.8MPending
Estimate$81.1M$134.2M$244.0M$213.8M$258.8M$227.8M$215.0M$215.0M
Surprise+217.6%+57.8%0.0%+25.3%−41.4%−5.0%−2.0%
Estimate$5.71
ReportedDue Nov 17, 2026
Estimate$215.0M
ReportedDue Nov 17, 2026
View details

Debt to equity88.10%
Current ratio499.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$78.8M$257.6M$211.8M$244.0M$267.8M$151.7M$216.5M$210.8M
Net income−$8.8M$61.7M$14.6M−$17.7M$55.4M$11.8M$46.8M$65.8M
Net margin0.0%23.9%6.9%0.0%20.7%7.8%21.6%31.2%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$9.7M$114.2M$72.2M$33.7M$130.4M$30.9M$81.3M$121.7M
YoY growthTurned profitTurned profit+4,881.3%+535.6%+1,249.2%−72.9%+12.5%+261.4%

Balance sheet, Jun 30, 2026Cash & short-term investments $205.2M · Total debt $347.3M · Total assets $964.6M · Shareholders' equity $394.3M

Revenue
$210.8M
Operating income
$121.7M
Net income
$65.8M
View details

No dividends on record.

Institutions≈ 42.79%2.93M shares
156 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders59.93%4.10M shares
14 holders · as of Sep 18, 2026
Adds to102.72%

6.85M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 102.72%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Thomas T. VoInsiderdirector, officer: Chief Executive Officer
30.71%2.10Mfiled May 29, 2026
Meeshanthini DoganInsiderdirector, officer: Chief Executive Officer
24.17%1.66Mfiled Oct 7, 2024
Pertento Partners LLPInstitution
6.59%451,310as of Jun 30, 2026
BlackRock, Inc.Institution
5.95%407,349as of Jun 30, 2026
American Century Companies IncInstitution
3.47%237,414as of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 18, 2026Scott J. Saundersdirector−203$214.25
Mar 20, 2026Frank E. Jaumotdirector+150$93.56
Mar 19, 2026Warren Hosseiniondirector, officer: President+252$94.07
Mar 17, 2026Kelvin Spearsdirector+10$94.46
Mar 13, 2026Pamela W. Montgomeryofficer: Chief Legal Officer-Healthcare+79$88.87
View details

Compare

CompanyPriceChange
Nutex Health$202.98−2.80%$1.44B8.37.81.7−13.6%
HCA Healthcare$436.51−0.37%$94.85B14.714.31.2+8.7%
Tenet Healthcare$256.97−1.94%$21.10B10.112.31.0+6.8%
Universal Health Services$183.15+2.15%$10.85B7.48.00.6+8.3%
Community Health Systems$3.04+0.50%$425.8M0.0−9.8%
Privia Health$19.07−2.00%$2.45B89.749.61.0+21.4%
Astrana Health$33.25−5.30%$1.74B42.920.10.5+48.5%
Agilon Health$85.32−1.75%$1.45B0.2+7.2%
Evolent$3.69−3.03%$427.4M11.00.2+46.9%
Median14.713.30.5+8.5%